We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Following in the steps of authorities in the European Union, Australia and the United Kingdom, the FDA has pledged to crack down on homeopathic treatments with a new “risk-based enforcement approach”, the US regulator has revealed in a draft guidance.